Patriot Financial Group Insurance Agency’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NBIX
BG
Patriot Financial Group Insurance Agency's NBIX Position: Q4 2024 in Review
Patriot Financial Group Insurance Agency sold out of Neurocrine Biosciences (NBIX) in Q4 2024, closing a stake of 1,788 shares — an estimated $206K sold.
Patriot Financial Group Insurance Agency first reported a position in NBIX in Q1 2020 and held it in 16 quarters. The position peaked at $256K in Q1 2024. 601 funds tracked by Wall St. Rank hold NBIX as of Q4 2024.
- Patriot Financial Group Insurance Agency reported no remaining Neurocrine Biosciences position as of Q4 2024 after selling out during the quarter.
- Patriot Financial Group Insurance Agency sold 1,788 Neurocrine Biosciences shares in Q4 2024, an estimated $206K.
- Patriot Financial Group Insurance Agency first reported a position in Neurocrine Biosciences in Q1 2020 and held it in 16 quarters.
- Patriot Financial Group Insurance Agency's Neurocrine Biosciences position peaked at $256K in Q1 2024.
- 601 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q4 2024.
Based on Patriot Financial Group Insurance Agency's 13F filing for Q4 2024, filed 22 Jan 2025.